Cite
HARVARD Citation
Kim, T. et al. (2018). Targeting insulin‐like growth factor 2 mRNA‐binding protein 1 (IGF2BP1) in metastatic melanoma to increase efficacy of BRAFV600E inhibitors. Molecular carcinogenesis. 57 (5), pp. 678-683. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kim, T. et al. (2018). Targeting insulin‐like growth factor 2 mRNA‐binding protein 1 (IGF2BP1) in metastatic melanoma to increase efficacy of BRAFV600E inhibitors. Molecular carcinogenesis. 57 (5), pp. 678-683. [Online].